Government of Canada Federal AIDS Initiative Milestones

Similar documents
The Federal Initiative To Address HIV/AIDS in Canada. Canada s Domestic Response to HIV/AIDS

Understanding HIV/AIDS: The current state of the HIV epidemic in British Columbia Mark Gilbert, MD, MHSc, FRCPC

Summary: Estimates of HIV Prevalence and Incidence in Canada, 2011

The epidemiology of HIV in Canada

World Health Organization. A Sustainable Health Sector

WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections

Saskatchewan HIV Strategy: Social Network Approach

Program to control HIV/AIDS

GLOBAL AIDS MONITORING REPORT

2010 HIV Prevention Plan and HIV Prevention Section Update

FRAMEWORK DOCUMENT. New HIV Prevention Technologies: Regulatory, policy, programming and research implications for Canada.

2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany

SASKATCHEWAN S HIV STRATEGY UPDATE

Epidemiology of Acute Hepatitis C Infection in Canada Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS)

Ministry of Health Population Health Branch

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030

The epidemiology of hepatitis C in Canada

As a result of this training, participants will be able to:

Harm Reduction in Nigeria

Towards universal access

Viral Hepatitis. WHO Regional Office for Europe July 2013

Focusing Our Efforts Ontario s Proposed HIV/AIDS Strategy to 2025

GLOBAL AIDS RESPONSE PROGRESS REPORTING (GARPR) 2014 COUNTRY PROGRESS REPORT SINGAPORE

IFMSA Policy Statement Ending AIDS by 2030

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

Sexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012

Technical Guidance Note for Global Fund HIV Proposals

Estimates of HIV Prevalence and Incidence in Canada, 2011

Integration of collaborative TB/HIV activities with harm reduction services

Reducing Harm or Producing Harm? Public Health Implications of Prosecuting HIV-positive People. Warren Michelow

Part 1: Introduction & Overview

New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016

UNGASS Country Progress Report. Government of Canada. of the United Nations on the

Sex Work in Sub-Saharan Africa : Opportunities and Challenges

People Living with HIV/AIDS in Canada: A Determinants of Health Perspective Preliminary Findings of the Population-Specific HIV/AIDS Status Report

ECDC update to the EU Commission Think Tank on HIV/AIDS

Percent of clients linked to care within 3 months of diagnosis: 87.60% FY16 Performance Outcomes (to date)

HIV, HBV and HCV testing policy experiences and lessons learned.

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

Healthy Pathways Forward Progress Report. May

HIV and AIDS among Aboriginal peoples in Canada: An Epidemiological Overview

Version for the Silent Procedure 29 April Agenda item January Hepatitis

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

DHMH Activities toward Implementing Requirements of Md. Code Ann., Health-General , Hepatitis C Prevention and Control within Maryland

HIV PREVENTION: NHAS TO HIP

Review on HIV & Associated Infections in Latvia

Harm reduction among drug users in Spain

HIV Epidemiology March 7, Stefanie Rhodes Inova Juniper Program

Provincial Infectious Diseases Advisory Committee Public Health Response to Hepatitis C

DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS

UNGASS COUNTRY PROGRESS REPORT SINGAPORE

Strategic use of antiretroviral drugs to prevent HIV transmission

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Comprehensive Epi Update: HIV, AIDS and STI Mark Gilbert, MD

HIV and AIDS in Northern Inter- Tribal Health Authority

Manitoba Health Statistical Update on HIV/AIDS

Opportunities For Hepatitis C Modalities in Substance Use Treatment Settings

HIV/AIDS MODULE. Rationale

As a result of this training, participants will be able to:

HIV AND PEOPLE WHO INJECT DRUGS

KENYA AIDS STRATEGIC FRAMEWORK 2014/ /2019

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

Translating Science to end HIV in Latin America and the Caribbean

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

Strategic Planning for HIV/AIDS

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

ART for prevention the task ahead

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

HIV - Preventing New Infections: New Options, Readjusted Approaches

BUDGET AND RESOURCE ALLOCATION MATRIX

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

PREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES

IDU Outreach Project. Program Guidelines

Preventing HIV Transmission in Intimate Partner Relationships

Improving outcomes The UK s achievements in managing and preventing the HIV epidemic and how we should approach public health priorities

HIV/AIDS Epi Update Public Health Agency of Canada

Closing the Gap: Integrated HIV/AIDS and Hepatitis C Strategic Directions for Vancouver Island Health Authority 2006/ /09

The President s Emergency Plan for AIDS Relief: Indicators, Reporting Requirements, and Guidelines for Focus Countries. Revised for FY2006 Reporting

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

Implementation of testing (and other interventions along the Continuum of Care)

ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS

National Aboriginal AIDS Awareness Week 2014: Leaders gather in Regina to announce Indigenous HIV and AIDS Strategy

NYS PrEP Programming. Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg

Consultation on the Draft National Strategies for Blood Borne Viruses and Sexually Transmissible Infections

ECDC and Spanish Ministry of Health workshop:

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres

Lessons learnt from other screening programmes : the case of HIV screening

UNGASS COUNTRY PROGRESS REPORT Republic of Armenia

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

Click to edit Master title style

Linkage of hepatitis and HIV surveillance systems to improve completeness of injection drug use risk data for co-infected Floridians

Policy Overview and Status of the AIDS Epidemic in Zambia

ECDC s role in the fight against HIV/AIDS in Europe

UNGASS Indicators and possible adoption of NDPHS indicators. Tallinn /P.Leinikki

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

Improving NSP and Harm Reduction Services. Jason Farrell, European HCV and Drug Use Initiative

Stigma and HIV. Maria E. Alvarez, MPA. LEAD PUBLIC HEALTH ADVISOR Team Lead, Capacity Building Branch Partnerships Team

Transcription:

HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for Infectious Disease Prevention & Control, PHAC Government of Canada Federal AIDS Initiative Milestones 2 2 $72.6M $34.0M $37.3M $42.2M $42.2M $47.2M $20.0M $3.2M $3.2M 1983 First federal investment in HIV/AIDS 1985 First federal funding to community AIDS Vancouver 1986 Federal Centre for AIDS established 1988 Federal Centre for AIDS funding 1990 National AIDS Strategy I 1994 National AIDS Strategy II 1998 Canadian Strategy on HIV/AIDS 2004 The Federal Initiative to Address HIV/AIDS in Canada 1

Government of Canada s Response to HIV/AIDS Three Major Initiatives 3 3 Federal Initiative Domestic Response (FI) Canadian HIV Vaccine Initiative (CHVI) CIDA International Response Overview of the Federal Initiative to Address HIV/AIDS in Canada 2008-09 4 4 Strategic Areas of Focus Programs and Policy Interventions Includes G&C funding programs AIDS Community Action Program National HIV/AIDS Funding Program FNIHB On-reserve Program Knowledge Development Surveillance & Epidemiology Laboratory Science Research Communications & Social Marketing Coordination, Evaluation & Reporting Global Engagement Correctional Service Canada $4.2M 6% Health Canada $5.5M 8% Canadian Institutes of Health Research $20.6M 28% Public Health Agency of Canada $42.3M, 58% 2

5 HIV in Canada This presentation is based on an environmental scan written by CATIE Conducted to: Address the need for a more integrated approach to KE As a starting point for dialogue among stakeholders in HIV To complement other initiatives underway by PHAC and CATIE 6 An estimated 58,000 Canadians were living with HIV in 2005 Comparison of HIV Adult Prevalence rates in 2008 Overall rate in world: 0.8% Australia 0.2% UK 0.2% Canada 0.3% France 0.4% Brazil 0.6% United States 0.6% Haiti 2.2% South Africa 18.1% 3

7 HIV in Canada is a concentrated epidemic HIV disproportionately affects specific vulnerable populations In some vulnerable populations the prevalence of HIV has been estimated to be as high as 23% (based on a research study in MSM in Toronto in 2007 called M Track) Concentrated epidemics demand interventions designed for the specific vulnerable populations The Public Health Agency of Canada supports a populationspecific approach to HIV prevention 8 HIV in Vulnerable Populations Among Canadians living with HIV: An estimated 55% are gay men or other men who have sex with men (MSM)* An estimated 21% are people who inject drugs (IDU)** An estimated 27% acquired HIV through heterosexual sex This is comprised of: 12% in people from countries where HIV is endemic 15% in people from countries where HIV in not endemic An estimated 20% are women An estimated 8% are Aboriginal people An estimated 2% of prisoners are HIV positive *this estimates includes 51% who HIV status is attributable to MSM and 4% whose HIV status could either be attributed to MSM or IDU **this estimate includes 17% whose HIV status is attributable to IDU and 5% whose HIV status could either be attributed to MSM or IDU 4

9 An estimated 2,300 4,500 people were newly infected with HIV in Canada in 2005 Primary modes of HIV transmission An estimated 45% of new cases were attributed to sex between men (MSM) An estimated 37% of new cases were attributed to heterosexual sex An estimated 14% of new cases were attributed to injection drug use (IDU) An estimated 3% of new cases could have been attributed to either MSM or IDU An estimated 1% of new cases were attributed to other risk factors Modes of HIV transmission that are now rare Blood transfusions Mother to child transmission (if HIV is diagnosed and treated in the mother) 10 An estimated 27% of people with HIV do not know their HIV status Up to 50% of new transmissions are attributable to people who are newly infected and have a high viral load (Research results from a study in Montreal) Once diagnosed with HIV, most people take steps to protect their partners Increasing testing is essential this includes promotion of early and regular testing and increased recognition of sero conversion symptoms 5

11 The HIV epidemic in Canada is connected with other infectious diseases Hepatitis C (HCV) 250,000 Canadians are living with HCV Primary mode of transmission is sharing drug equipment (HCV is approximately 10 times more infectious through blood contact than HIV) Among people who acquired HIV through injection drug use, approximately 50 to 90% are co infected with HCV Testing for HCV among HIV positive people and for HIV among HCV positive people is essential 12 Sexually Transmitted Infections (STIs) There has been a two fold to four fold increase in reportable STIs among Canada over the last 10 years STIs significantly increase the risk of HIV transmission and acquisition High rates of STIs are often a marker for HIV risk behaviours Testing for STIs among HIV positive people and for HIV in people with an STI is essential Tuberculosis (TB) 2% to 6% of Canadians with HIV have active TB Having HIV increases the risk for acquiring TB Testing for TB among HIV positive people and for HIV in people with TB is essential 6

13 Evidence Informed Approach to HIV Programs Combination prevention strategies that provide a best mix of prevention programs are recommended Education and behavioural interventions (Outreach, sexual health education, harm reduction) Enhanced HIV testing and counselling Addressing factors that cause vulnerability to HIV (stigma and discrimination, unstable living conditions, barriers to accessing health services) Adopting biomedical approaches to prevention (Post exposure prophylaxis, diagnosing and treating STIs to reduce infectiousness, enhancing access to HIV treatment to reduce population level viral load, prevention of mother to child transmission) The challenge for public health is to determine the best mix of prevention programs and the necessary coverage to reverse the epidemic 14 Evidence Informed Approach to HIV Programs Trend towards programming that integrates HIV prevention, diagnosis, care, treatment and support Connecting outreach with testing and counselling programs (role of rapid point of care testing is being explored in various regions of Canada) Connecting testing and counselling with access to treatment (including reducing viral load and accessing Post exposure prophylaxis) Positive prevention for people with HIV as an integrated approach to prevention, care and support The challenge for public health is to explore new integrated approaches for vulnerable populations that are informed by the latest research 7

15 8